Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VitalTE is a regenerative medicine company developing scaffold-free, tissue-engineered implants to treat damaged or diseased tissues. A spin-out from the University of California, Irvine, the company leverages a proprietary self-assembly platform to create functional biological replacements for cartilage and cardiovascular structures. Their technology aims to produce tissues that match the mechanical and biochemical properties of native human tissue without the use of synthetic scaffolds. VitalTE's primary focus areas include the treatment of Temporomandibular Joint (TMJ) disorders and knee cartilage defects. The company's approach represents a significant advancement in tissue engineering by avoiding the inflammatory responses often associated with foreign materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VitalTE.